TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27553010

Group type: EXPERIMENTAL
Intervention: Born to Move (BTM) intervention
Number of subjects: 139

Group type: COMPARATOR
Intervention: Control (COM) group
Number of subjects: 139
Study: 24907879

Group type: EXPERIMENTAL
Intervention: Airtraq™ laryngoscope
Number of subjects: 132

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 132
Study: 22324055

Group type: EXPERIMENTAL
Intervention: Adapted Physical Activities (G1)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Wii Fit(®) (G2)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Adapted Physical Activities + Wii Fit(®) (G3)
Number of subjects: 36

Group type: COMPARATOR
Intervention: No training (G4)
Number of subjects: 36
Study: 20678306

Group type: EXPERIMENTAL
Intervention: Mometasone furoate/formoterol 200/10 microg (MF/F)
Number of subjects: 781

Group type: COMPARATOR
Intervention: Mometasone furoate 200 microg (MF)
Number of subjects: 781

Group type: COMPARATOR
Intervention: Formoterol 10 microg (F)
Number of subjects: 781

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 781
Study: 19000211

Group type: EXPERIMENTAL
Intervention: Photographs of scenes interrupted by a 42‐ms or 250‐ms mask, 250 ms into viewing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Photographs of scenes changed after interruption
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interruption included a saccade
Number of subjects: 0
Study: 15718305

Group type: EXPERIMENTAL
Intervention: Docetaxel 75 mg/m² once every 3 weeks
Number of subjects: 51
Study: 12212960

Group type: EXPERIMENTAL
Intervention: Cylinder O2
Number of subjects: 41

Group type: COMPARATOR
Intervention: Cylinder air
Number of subjects: 41
Study: 10340423

Group type: EXPERIMENTAL
Intervention: Intrathecal baclofen (50 microg bolus injection)
Number of subjects: 6
Study: 8549019

Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study: 1662941

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH)
Number of subjects: 0
Study: 7102728

Group type: EXPERIMENTAL
Intervention: Methylphenidate (active medication)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 10
Study: 31039763

Group type: EXPERIMENTAL
Intervention: Bone marrow-derived mesenchymal cells (BM-MSCs) mixed with platelet-rich plasma (PRP), thrombin, and calcium, plus β-tricalcium phosphate (β-TCP) for bone regeneration.
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: BM-MSCs treatment
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 83
Study: 27669653

Group type: COMPARATOR
Intervention: Outpatient surgery
Number of subjects: 7767

Group type: COMPARATOR
Intervention: Inpatient surgery
Number of subjects: 7767

Group type: COMPARATOR
Intervention: Gynecologists
Number of subjects: 7767

Group type: COMPARATOR
Intervention: Resident participation
Number of subjects: 7767
Study: 26669546

Group type: EXPERIMENTAL
Intervention: Immediate implant placement (25 patients)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Delayed implant placement (25 patients)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Immediate group (25 patients)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Delayed group (23 patients)
Number of subjects: 50
Study: 24932599

Group type: EXPERIMENTAL
Intervention: Carbohydrate counting
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control
Number of subjects: 84
Study: 22947443

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation in addition to chest physiotherapy (8 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Chest physiotherapy (8 weeks)
Number of subjects: 30
Study: 19716961

Group type: EXPERIMENTAL
Intervention: Roflumilast 500 microg once a day for 24 weeks with salmeterol
Number of subjects: 837

Group type: EXPERIMENTAL
Intervention: Roflumilast 500 microg once a day for 24 weeks with tiotropium
Number of subjects: 837

Group type: COMPARATOR
Intervention: Roflumilast
Number of subjects: 837
Study: 17449929

Group type: EXPERIMENTAL
Intervention: Reduced intensity conditioning (fludarabine/melphalan, fludarabine/cyclophosphamide)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Myeloablative conditioning (busulfan/cyclophosphamide)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Reduced intensity conditioning
Number of subjects: 75

Group type: COMPARATOR
Intervention: Myeloablative conditioning
Number of subjects: 75
Study: 15229004

Group type: EXPERIMENTAL
Intervention: Preterm deliveries after spontaneous initiation of labor without maternal complications
Number of subjects: 3304

Group type: EXPERIMENTAL
Intervention: Medically indicated preterm deliveries with maternal obstetric and medical complications
Number of subjects: 3304

Group type: EXPERIMENTAL
Intervention: Preterm deliveries after prelabor spontaneous rupture of amniotic membranes (PROM) with complications
Number of subjects: 3304

Group type: EXPERIMENTAL
Intervention: Preterm deliveries with obstetric and medical complications
Number of subjects: 3304

Group type: EXPERIMENTAL
Intervention: Clinical presentation (PROM or medically indicated)
Number of subjects: 3304
Study: 12195603

Group type: EXPERIMENTAL
Intervention: Tiotropium 18 micro g once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ipratropium bromide 40 micro g four times daily
Number of subjects: 0
Study: 9578047

Group type: EXPERIMENTAL
Intervention: 10 mg midazolam (MDL) in 2 ml peppermint-flavored fluid
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (peppermint-flavored fluid)
Number of subjects: 10
Study: 10522780

Group type: EXPERIMENTAL
Intervention: Controlled-release of subgingivally delivered doxycycline hyclate in a polylactic acid based polymer gel
Number of subjects: 358

Group type: COMPARATOR
Intervention: Scaling and root planing alone (SRP)
Number of subjects: 358
Study: 2072698

Group type: EXPERIMENTAL
Intervention: Intraluminal radiotherapy (ILRT) plus concurrent 5-fluorouracil (5-FU) infusion
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intraluminal radiotherapy (ILRT) alone
Number of subjects: 50
Study: 6849205

Group type: EXPERIMENTAL
Intervention: 500 mg metronidazole intravenously every 6 hours for three doses
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study: 30730785

Group type: EXPERIMENTAL
Intervention: 1 mg of folic acid for 16 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo for 16 weeks
Number of subjects: 80
Study: 29573207

Group type: EXPERIMENTAL
Intervention: Rolontis 270 μg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rolontis 135 μg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rolontis 45 μg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pegfilgrastim 6 mg
Number of subjects: 0
Study: 26853325

Group type: EXPERIMENTAL
Intervention: Dexamethasone (12 mg/day for 3 weeks followed by tapering)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 20
Study: 25314962

Group type: EXPERIMENTAL
Intervention: Communities First regeneration scheme
Number of subjects: 4226
Study: 23304687

Group type: EXPERIMENTAL
Intervention: High insertion torque (>80 Ncm)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Medium insertion torque (25 to 35 Ncm)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 19864114

Group type: EXPERIMENTAL
Intervention: First-generation antipsychotic (perphenazine)
Number of subjects: 623

Group type: EXPERIMENTAL
Intervention: Second-generation antipsychotic (quetiapine)
Number of subjects: 623
Study: 18297829

Group type: EXPERIMENTAL
Intervention: Fast-curing mode of LED curing light (Mini LED)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Step-curing mode of LED curing light
Number of subjects: 30
Study: 15712594

Group type: EXPERIMENTAL
Intervention: Flavanol-containing milk chocolate (FCMC)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Cocoa butter chocolate (CBC)
Number of subjects: 28
Study: 11896327

Group type: EXPERIMENTAL
Intervention: PEN110 treatment (pathogen-inactivated RBCs)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control units (additive system control)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: PEN110 treatment
Number of subjects: 12
Study: 9008372

Group type: EXPERIMENTAL
Intervention: High self-esteem (manipulated in Experiment 1; dispositional in Experiment 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Moderate self-esteem
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High self-esteem
Number of subjects: 0
Study: 8314495

Group type: EXPERIMENTAL
Intervention: Interferon in acute hepatitis C
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 3571503

Group type: EXPERIMENTAL
Intervention: Subliminal presentation of positive emotional concepts
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Supraliminal presentation of positive emotional concepts
Number of subjects: 36

Group type: COMPARATOR
Intervention: Subliminal presentation of negative emotional concepts
Number of subjects: 36
Study: 30326888

Group type: EXPERIMENTAL
Intervention: Non-invasive diabetes risk prediction model (German Diabetes Risk Score) used during routine health check.
Number of subjects: 300

Group type: COMPARATOR
Intervention: Routine health check 'Check-up 35' (control group).
Number of subjects: 300
Study: 27650139

Group type: EXPERIMENTAL
Intervention: Lip training with 200 or 400 g of bottled water in the oral vestibule
Number of subjects: 66
Study: 25183507

Group type: EXPERIMENTAL
Intervention: Inhalation of rosemary essential oil for three minutes
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Inhalation of lavender essential oil for three minutes
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Inhalation of eucalyptus essential oil for three minutes
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control for cardiovascular variables (HR and BP)
Number of subjects: 33
Study: 22613015

Group type: EXPERIMENTAL
Intervention: Intervention A (written information - leaflet describing correct inhalation techniques)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Intervention B (written information about inhalation techniques plus training by an instructor)
Number of subjects: 495

Group type: COMPARATOR
Intervention: Control arm (not specified in detail)
Number of subjects: 495
Study: 20230348

Group type: EXPERIMENTAL
Intervention: Employment of a project nurse to encourage best-practice falls injury prevention strategies during a 17-month intervention period.
Number of subjects: 5391

Group type: COMPARATOR
Intervention: Control facilities (not specified intervention).
Number of subjects: 5391
Study: 18986788

Group type: EXPERIMENTAL
Intervention: Ranolazine
Number of subjects: 12
Study: 16439851

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment (1 or 2 mg/m2/day)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment
Number of subjects: 79
Study: 12705644

Group type: EXPERIMENTAL
Intervention: Zero-balanced ultrafiltration (ZBUF)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 11593632

Group type: EXPERIMENTAL
Intervention: 50 mg of tPA (Group I; n = 26)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 1.0-1.5 million U of urokinase (Group II; n = 54)
Number of subjects: 80
Study: 8876751

Group type: EXPERIMENTAL
Intervention: Bilateral strength training (BIL)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Unilateral strength training (UNIL)
Number of subjects: 48
Study: 1376503

Group type: EXPERIMENTAL
Intervention: Conventional histology (CH)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Fine‐needle aspiration cytology (FNAC)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Monoclonal antibody staining of needle core biopsies (MABS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 50
Study: 4037535

Group type: EXPERIMENTAL
Intervention: Smoggy Los Angeles ambient air exposure
Number of subjects: 59

Group type: COMPARATOR
Intervention: Purified air exposure (control)
Number of subjects: 59
Study: 30861351

Group type: EXPERIMENTAL
Intervention: Combined training exercise program (CTE) for 16 weeks, 3 times a week
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 49
Study: 29210808

Group type: EXPERIMENTAL
Intervention: Haloperidol (1 mg twice daily for 7 days)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo (twice daily for 7 days)
Number of subjects: 29
Study: 26684684

Group type: EXPERIMENTAL
Intervention: Tulip GT airway
Number of subjects: 60

Group type: COMPARATOR
Intervention: Facemask with Guedel airway
Number of subjects: 60
Study: 24708591

Group type: EXPERIMENTAL
Intervention: Increased dairy intake by 3.0 (± 1.2) serves/day for 1 month
Number of subjects: 180

Group type: COMPARATOR
Intervention: Decreased dairy intake by 2.5 (± 1.2) serves/day
Number of subjects: 180

Group type: COMPARATOR
Intervention: No change in dairy intake
Number of subjects: 180
Study: 22126416

Group type: EXPERIMENTAL
Intervention: CD-sens to peanut
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: IgE-antibody to Ara h 1, 2, and 3
Number of subjects: 38
Study: 19522751

Group type: EXPERIMENTAL
Intervention: Celecoxib (400 mg/day for 9 days after bout 1)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 18630774

Group type: EXPERIMENTAL
Intervention: Caffeine benzoate, 20 mg/kg IV
Number of subjects: 72

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 72
Study: 15685028

Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 930

Group type: COMPARATOR
Intervention: Pamidronate
Number of subjects: 930

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (multiple myeloma subgroup)
Number of subjects: 930

Group type: COMPARATOR
Intervention: Pamidronate (multiple myeloma subgroup)
Number of subjects: 930

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (breast cancer subgroup)
Number of subjects: 930

Group type: COMPARATOR
Intervention: Pamidronate (breast cancer subgroup)
Number of subjects: 930
Study: 12122787

Group type: COMPARATOR
Intervention: X‐ray stimulation radiotherapy (6 x 0.5 Gy, 1 fraction/day)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Extracorporeal Shock Wave Therapy (ESWT, 2000 pulses, energy flux density ED+ 0.1 mJ/mm2, 3 times in 1 week intervals)
Number of subjects: 30
Study: 10607226

Group type: EXPERIMENTAL
Intervention: Consensus interferon (IFN) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: IFN‐alpha2b treatment
Number of subjects: 0
Study: 7781857

Group type: EXPERIMENTAL
Intervention: gemeprost
Number of subjects: 67

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 67
Study: 2114064

Group type: EXPERIMENTAL
Intervention: Enteral diet comprising 55% fats
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 10
Study: 913045

Group type: EXPERIMENTAL
Intervention: Subcutaneous injection of adrenaline
Number of subjects: 0
Study: 31865758

Group type: EXPERIMENTAL
Intervention: Insulin glargine 300 U/mL (Gla-300)
Number of subjects: 1312

Group type: COMPARATOR
Intervention: Standard of Care (SoC) basal insulins
Number of subjects: 1312
Study: 31018017

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Person‐Centred Experiential Therapy (PCET)
Number of subjects: 96
Study: 28687551

Group type: EXPERIMENTAL
Intervention: Nebulized morphine 20 mg every 4 hours
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Nebulized fentanyl 25 and 100 μg
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Nebulized hydromorphone 5 mg
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Nebulized morphine-6-glucuronide
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Other nebulized opioids (various doses)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 181
Study: 25047796

Group type: COMPARATOR
Intervention: Intravenous dexketoprofen trometamol (50 mg) and intraarticular normal saline (20 mL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intraarticular 0.5 % levobupivacaine (100 mg) and intravenous normal saline (2 mL)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intraarticular 0.5 % levobupivacaine (100 mg) and intravenous dexketoprofen trometamol (50 mg)
Number of subjects: 60
Study: 22717938

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) intervention for caregivers
Number of subjects: 140
Study: 19346278

Group type: EXPERIMENTAL
Intervention: Tiagabine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (non-medicated group)
Number of subjects: 60
Study: 18157648

Group type: EXPERIMENTAL
Intervention: Microsurgery plus whole brain irradiation (WBRT)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Gamma Knife surgery alone
Number of subjects: 64
Study: 15684155

Group type: EXPERIMENTAL
Intervention: Oxytocin bolus (10 IU push)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Dilute oxytocin infusion (10 IU in 500 mL saline at 125 mL/h)
Number of subjects: 201
Study: 12851521

Group type: EXPERIMENTAL
Intervention: Continuous‐combined hormone replacement therapy (0.625 mg/day conjugated equine estrogen plus 5 mg/day medroxyprogesterone)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no HRT treatment)
Number of subjects: 40
Study: 10066720

Group type: EXPERIMENTAL
Intervention: Initial body temperature of 36 degrees C
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Initial body temperature of 37 degrees C
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Initial body temperature of 38 degrees C
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: High rate of heat storage (0.10 degrees C/min)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Low rate of heat storage (0.05 degrees C/min)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: High rate of heat storage
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Low rate of heat storage
Number of subjects: 7
Study: 8739809

Group type: EXPERIMENTAL
Intervention: Isoproterenol
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Amrinone
Number of subjects: 16
Study: 1912052

Group type: EXPERIMENTAL
Intervention: 1988 survey
Number of subjects: 1352

Group type: EXPERIMENTAL
Intervention: 1989 survey
Number of subjects: 1352

Group type: COMPARATOR
Intervention: 1988 and 1989 surveys
Number of subjects: 1352
Study: 6758933

Group type: EXPERIMENTAL
Intervention: Tiapamil (intravenous and/or oral)
Number of subjects: 22
Study: 29228473

Group type: EXPERIMENTAL
Intervention: Desvenlafaxine (50, 100, and 200 mg)
Number of subjects: 30
Study: 27043082

Group type: EXPERIMENTAL
Intervention: Losmapimod (7.5 mg, twice daily)
Number of subjects: 3503

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3503

Group type: EXPERIMENTAL
Intervention: Losmapimod
Number of subjects: 3503
Study: 24910199

Group type: EXPERIMENTAL
Intervention: High-intensity exercise (80% of VO2max) for 40 min
Number of subjects: 6

Group type: COMPARATOR
Intervention: Low-intensity exercise (40% of VO2max) for 20 min
Number of subjects: 6
Study: 22810991

Group type: EXPERIMENTAL
Intervention: Grape polyphenol powder (GRAPE)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 20557835

Group type: EXPERIMENTAL
Intervention: S-etodolac ER 300 mg
Number of subjects: 108

Group type: COMPARATOR
Intervention: etodolac ER 600 mg
Number of subjects: 108
Study: 18401713

Group type: EXPERIMENTAL
Intervention: Supported employment program
Number of subjects: 194

Group type: COMPARATOR
Intervention: Stepwise vocational program
Number of subjects: 194
Study: 16391215

Group type: EXPERIMENTAL
Intervention: Low-fat dietary intervention with group and individual sessions promoting decreased fat intake and increased vegetable, fruit, and grain consumption.
Number of subjects: 48835

Group type: COMPARATOR
Intervention: Control group receiving diet-related education materials.
Number of subjects: 48835
Study: 12817528

Group type: COMPARATOR
Intervention: Repaglinide alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repaglinide with ketoconazole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repaglinide with ethinyloestradiol/levonorgestrel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repaglinide with simvastatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repaglinide with nifedipine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repaglinide with ketoconazole and rifampicin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repaglinide with simvastatin or nifedipine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repaglinide with CYP3A4 substrates (ethinyloestradiol/levonorgestrel, simvastatin, nifedipine)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repaglinide with strong inhibitors or inducers of CYP3A4
Number of subjects: 0
Study: 11293210

Group type: COMPARATOR
Intervention: Intramuscular vaccination
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Intradermal vaccination
Number of subjects: 76
Study: 8880180

Group type: EXPERIMENTAL
Intervention: Distortion product otoacoustic emission (DPOAE) iso-suppression tuning curves (STC)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: DPOAE STC
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Psychoacoustic tuning curves (PTC)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Neonatal STCs
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: DPOAE suppression
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Cochlear tuning
Number of subjects: 31
Study: 2057103

Group type: EXPERIMENTAL
Intervention: phytostimolin cream and vaginal lavage
Number of subjects: 60
Study: 6337761

Group type: EXPERIMENTAL
Intervention: Indenolol (30- or 60-mg tablets, twice daily for 14 days)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (for 3 days prior to indenolol)
Number of subjects: 14
Study: 31257605

Group type: EXPERIMENTAL
Intervention: Policy and environmental change intervention
Number of subjects: 636

Group type: COMPARATOR
Intervention: Delayed intervention (control)
Number of subjects: 636
Study: 30557350

Group type: EXPERIMENTAL
Intervention: Peer-assisted learning with simulation-based training for postpartum hemorrhage and neonatal asphyxia management
Number of subjects: 199

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: All groups combined
Number of subjects: 199
Study: 26628249

Group type: EXPERIMENTAL
Intervention: Multisystemic Therapy‐Health Care (MST‐HC)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 170